Evidence map›Paper›PMID 41641849›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026

A Bifunctional Small Molecule Degrader of the Long Noncoding RNA MALAT1 Triplex.

Christian A T Brega, Benjamin A Craig, Sigitas Mikutis, Rupert S J Proctor, Yuliia Vyborna, Galway Ivey, Maria Eleftheriou, Kostas Tzelepis, Mo Yang, Shaifaly Parmar and 3 more

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. A Bifunctional Small Molecule Degrader of the Long Noncoding RNA MALAT1 Triplex.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. RNA Triple Helices: From Structures and Mechanisms to Therapeutic Targets.International journal of biological sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christian A T BregaYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Benjamin A CraigYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Sigitas MikutisYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Rupert S J ProctorYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Yuliia VybornaYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Galway IveyYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Maria EleftheriouCambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Kostas TzelepisCambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Mo YangDepartment Chemical Biology Laboratory, Institution Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
Shaifaly ParmarDepartment Chemical Biology Laboratory, Institution Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
Javier Bonet-AletaYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
John S SchneeklothDepartment Chemical Biology Laboratory, Institution Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
Gonçalo J L BernardesYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.ORCID 0000-0001-6594-8917

Funding

Horizon 2020 859908NCI NIH HHS BC011585NIH HHS
6 · The paper itself

Abstract

The targeted degradation of RNA, particularly long noncoding RNAs (lncRNAs), holds immense potential for therapeutic interventions in diseases associated with aberrant RNA regulation. Here, we introduce a novel Proximity-Induced Nucleic Acid Degrader (PINAD-1), a first-in-class small molecule that selectively induces the degradation of MALAT1, a lncRNA implicated in the regulation of metastatic processes. PINAD-1 is designed by conjugating a binder specific for the triple helix structure of MALAT1 to an imidazole-based RNA-degrading warhead, enabling specific cleavage of the MALAT1 transcript in vitro and in cellulo, with minimal off-target effects on the structurally similar NEAT1 lncRNA. Through mechanistic studies, we show that effective RNA degradation is not solely dependent on proximity but requires a precise structural context, as demonstrated by the differential activity of PINAD-1 compared to the structurally analogous but functionally inert conjugate PINAD-2. Our findings underscore the importance of binder-induced destabilization and RNA geometry in facilitating RNA degradation. This work lays the foundation for the design of bifunctional small-molecule RNA degraders as powerful tools for the modulation of structured noncoding RNAs, offering potential applications in RNA-based therapeutics.

Indexed as

ImidazolesRNA, Long NoncodingSmall Molecule LibrariesHumansNucleic Acid ConformationRNA StabilityImidazolesMALAT1 long non-coding RNA, humanRNA, Long NoncodingSmall Molecule LibrariesdegradersMALAT1proximity inducedRNAsmall‐molecule

Identifiers

PMID41641849
PMCPMC13107498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.